PyInvesting

Market research

ZBH Zimmer Biomet Holdings Inc

NYSE USD Healthcare

Latest close

Loading market data…

Test a moving-average rule with historical data.

Market cap
19B
P/E ratio
24.04
Analyst target
107.5714
Dividend yield
1.0%
Beta
0.46

Community

Investor discussion

1 comment

Admin profile picture
Admin

5 years, 4 months ago

Zimmer Biomet Holdings, Inc is currently in a long term uptrend where the price is trading 1.2% above its 200 day moving average.

From a valuation standpoint, the stock is 99.6% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 4.8.

Zimmer Biomet Holdings, Inc's total revenue sank by 99.7% to $7M since the same quarter in the previous year.

Its net income has dropped by 100.0% to $-137K since the same quarter in the previous year.

Finally, its free cash flow fell by 333.6% to $-868M since the same quarter in the previous year.

Based on the above factors, Zimmer Biomet Holdings, Inc gets an overall score of 2/5.